ENDRA Life Sciences (NDRA) Current Assets (2016 - 2021)
ENDRA Life Sciences (NDRA) has disclosed Current Assets for 6 consecutive years, with $14.5 million as the latest value for Q3 2021.
- Quarterly Current Assets rose 202.75% to $14.5 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $14.5 million through Sep 2021, up 202.75% year-over-year, with the annual reading at $8.2 million for FY2020, 25.59% up from the prior year.
- Current Assets for Q3 2021 was $14.5 million at ENDRA Life Sciences, down from $16.3 million in the prior quarter.
- The five-year high for Current Assets was $18.4 million in Q1 2021, with the low at $265648.0 in Q1 2017.
- Average Current Assets over 5 years is $6.3 million, with a median of $4.8 million recorded in 2020.
- The sharpest move saw Current Assets surged 2907.34% in 2017, then crashed 86.17% in 2018.
- Over 5 years, Current Assets stood at $5.9 million in 2017, then rose by 18.15% to $6.9 million in 2018, then dropped by 5.96% to $6.5 million in 2019, then increased by 25.59% to $8.2 million in 2020, then surged by 76.3% to $14.5 million in 2021.
- According to Business Quant data, Current Assets over the past three periods came in at $14.5 million, $16.3 million, and $18.4 million for Q3 2021, Q2 2021, and Q1 2021 respectively.